Evidence map›Paper›PMID 37137863›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Research progress of radiomics in the evaluation of microvascular invasion in hepatocellular carcinoma].

L L Wang, J F Li, J Q Lei, S L Guo, Q H Guo, J Nan, R Wang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

L L WangFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Radiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
J F LiFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Infectious Diseases, Institute of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou 730000, China.
J Q LeiFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Radiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
S L GuoFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Radiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
Q H GuoFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Radiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
J NanFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China Department of Radiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
R WangFirst Clinical Medical School of Lanzhou University, Lanzhou 730000, China.

Funding

Hospital Fund from the First Hospital of Lanzhou University ldyyyn2020-14National Natural Science Foundation of China 81800528, 81960323
6 · The paper itself

Abstract

Microvascular invasion (MVI) is an independent predictor of early recurrence and poor prognosis following hepatocellular carcinoma (HCC) resection and transplantation. As a novel non-invasive diagnostic tool, radiomics can extract the quantitative imaging features of tumors and peritumoral tissues with high throughput, providing more information on tumor heterogeneity than conventional and functional imaging of visual analysis and having a good application prospect in predicting the presence of MVI in HCC patients, thereby improving the accuracy of HCC diagnosis and prognosis. The value of the multimodal radiomics method based on various imaging methods in evaluating the possibility of MVI in HCC patients is elucidated here in combination with the latest research progress.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsHumansNeoplasm InvasivenessPrognosisRetrospective StudiesHepatocellular carcinomaMicrovascular invasionRadiomics

Identifiers

PMID37137863
PMCPMC12814144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.